Paxillin CLIA Kit

Produktnummer ABIN6206895

Produktdetails Paxillin CLIA Kit

Target: Paxillin (PXN)

Reaktivität: Human

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.156 ng/mL - 10 ng/mL

Untere Nachweisgrenze: 0.156 ng/mL

Applikation: ELISA

Verwendungszweck: Human Paxillin (Pax) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates and other biological fluids.

Proben: Tissue Homogenate

Analytische Methode: Quantitative

Sensitivität: < 0.055 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: Paxillin (PXN)

Andere Bezeichnung: Paxillin (Pax) (PXN Produkte)

Synonyme: AW108311 CLIA Kit, AW123232 CLIA Kit, Pax CLIA Kit, CG18061 CLIA Kit, CG18576 CLIA Kit, CG31794 CLIA Kit, CT40481 CLIA Kit, CT42454 CLIA Kit, DPaxillin CLIA Kit, DPxn CLIA Kit, DPxn37 CLIA Kit, Dmel\\CG31794 CLIA Kit, Dpax CLIA Kit, DpaxA CLIA Kit, PDLP CLIA Kit, dPax CLIA Kit, pax CLIA Kit, wu:fw71f12 CLIA Kit, PXN CLIA Kit, LOC100220858 CLIA Kit, paxillin CLIA Kit, Paxillin CLIA Kit, paxillin S homeolog CLIA Kit, paxillin a CLIA Kit, PXN CLIA Kit, Pxn CLIA Kit, Pax CLIA Kit, pxn.S CLIA Kit, pxna CLIA Kit, LOC696336 CLIA Kit, pxn CLIA Kit

UniProt: P49023, F5GZ78, F5H836, H0YIE4, F8W0K8, F8W0G0, F8W1E0, F8VZ39

Pathways: MAPK Signalweg, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling